As of November 10, 2026, Tonix Pharmaceuticals Holding Corp. is a publicly traded company (Nasdaq: TNXP); its largest reported holder is Point72, with 6.9% on Schedule 13G/A of May 15, 2026, then BlackRock (6.7%). The largest insider holding is Seth Lederman, the chief executive and a director, with 31,007 shares (0.16% of shares outstanding), per Form 4 of August 31, 2026 (Schedule 13G/A, May 15, 2026).
Is this your company?
About to sign with, pay or invest in Tonix Pharmaceuticals Holding Corp.? See the free Snapshot first.
Free to see. No signup.
Is Tonix Pharmaceuticals Holding Corp. a real, registered company?
- Tonix Pharmaceuticals Holding Corp. files with the SEC under CIK 1430306 (its SEC filings).
- Its shares are listed under the ticker TNXP on Nasdaq (SEC company record).
- Incorporated in Nevada; business address in Berkeley Heights, New Jersey, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Tonix Pharmaceuticals Holding Corp. in our court records and SEC 8-K records (as of 2026-11-10).
- Leadership changes: the latest reported is Seth Lederman, Chief Medical Officer (Form 8-K filed 2026-08-18). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names AQR (filed 2026-08-13).
Who are Tonix Pharmaceuticals Holding Corp.'s owners and officers?
Tonix Pharmaceuticals Holding Corp.: incorporated in Nevada; business address in Berkeley Heights, New Jersey; industry Pharmaceutical Preparations (Form D, 2026-08-18).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-08-14 | Sirenia Capital Management LP | 4.9% |
| Schedule 13G, 2026-08-13 | Aqr Capital Management, LLC | 5.54% |
| Schedule 13G, 2026-06-15 | Millennium Management LLC | 5.6% |
| Schedule 13G/A, 2026-05-15 | Point72 Asset Management, L.P. | 6.9% |
| Schedule 13G, 2026-05-15 | Sirenia Capital Management LP | 8.8% |
| Schedule 13G/A, 2026-03-27 | The Vanguard Group | 0% |
| Schedule 13G/A, 2026-01-30 | The Vanguard Group | 5.02% |
| Schedule 13G/A, 2026-01-21 | Blackrock, Inc. | 6.7% |
| Schedule 13G, 2025-12-31 | Point72 Asset Management, L.P. | 9.2% |
| Schedule 13G, 2025-10-31 | The Vanguard Group | 6.35% |
| Schedule 13G/A, 2025-10-17 | Blackrock, Inc. | 7.8% |
| Schedule 13G, 2025-07-17 | Blackrock, Inc. | 5.7% |
Questions about who owns Tonix Pharmaceuticals Holding Corp.
Who owns Tonix Pharmaceuticals Holding Corp.?
On this page, 4 holders' latest ownership filings report 5% or more of Tonix Pharmaceuticals Holding Corp.: Point72 Asset Management, L.P. (6.9%, Schedule 13G/A, filed 2026-05-15), Blackrock, Inc. (6.7%, Schedule 13G/A, filed 2026-01-21), Millennium Management LLC (5.6%, Schedule 13G, filed 2026-06-15) and Aqr Capital Management, LLC (5.54%, Schedule 13G, filed 2026-08-13).
Who are the largest shareholders of Tonix Pharmaceuticals Holding Corp.?
By the share each holder's latest filing reports, the largest holders of Tonix Pharmaceuticals Holding Corp. on this page are Point72 Asset Management, L.P. (6.9%), Blackrock, Inc. (6.7%) and Millennium Management LLC (5.6%).
When did Point72 Asset Management, L.P. buy into Tonix Pharmaceuticals Holding Corp.?
The filings give report dates, not purchase dates. The earliest filing from Point72 Asset Management, L.P. on this page is the Schedule 13G, filed 2025-12-31, reporting 9.2%; its latest, Schedule 13G/A filed 2026-05-15, reports 6.9%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 12 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Tonix Pharmaceuticals Holding Corp.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Tonix Pharmaceuticals Holding Corp.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Tonix Pharmaceuticals Holding Corp. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
19 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-08-18 | Seth Lederman | Chief Medical Officer | appointed |
Which insiders own Tonix Pharmaceuticals Holding Corp. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , the chief executive and a director: 31,007 shares (0.16% of shares outstanding), 20,001 held directly and 11,006 indirectly (Form 4, 2026-08-31).
- , a director: 5,000 shares (0.03% of shares outstanding) (Form 4, 2026-06-09).
- , the chief financial officer: 2,154 shares (0.01% of shares outstanding) (Form 4, 2026-07-09).
- , a director: 1,833 shares (0.01% of shares outstanding) (Form 4, 2026-06-15).
- , a director: 1,000 shares (0.01% of shares outstanding) (Form 4, 2026-08-24).
Shares outstanding: 19,431,516 as of 2026-11-06, from the company's latest SEC cover page.
How much has Tonix Pharmaceuticals Holding Corp. raised?
No fundraising or offering filing from Tonix Pharmaceuticals Holding Corp. is on file with us.
Keep reading
More on Tonix Pharmaceuticals Holding Corp. and the records around it.
Tonix Pharmaceuticals Holding Corp. elsewhere on the record
- 5%+ stake filings Aug 2026
Companies that share a holder
- Sirenia Capital Management LP also filed stake reports on 19 other companies: Alto Neuroscience, Inc. (Aug 2026), ANAPTYSBIO, INC (Aug 2026), CYBIN INC. (Aug 2026)
- Point72 Asset Management, L.P. also filed stake reports on 90 other companies: Immunocore Holdings plc (Nov 2026), Target Hospitality Corp. (Nov 2026), E.W. SCRIPPS Co (Oct 2026)
- Millennium Management LLC also filed stake reports on 121 other companies: StepStone Group Inc. (Nov 2026), Catalyst Acquisition Corp. (Nov 2026), RxSight, Inc. (Nov 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/tonix-pharmaceuticals-holding